BSX · News · 20260810N

Revenue Performance and Mix

BOSTON SCIENTIFIC CORP · 2026-08-10 · Importance 36 · Surprise 14

Boston Scientific reported second-quarter 2026 revenue of $5.44 billion, representing 7.5% year-over-year growth. International electrophysiology sales increased 23.1%, while international WATCHMAN sales increased 17.7%. U.S. growth headwinds affected WATCHMAN and electrophysiology performance despite the overall quarterly increase.

Key facts

• BOSTON SCIENTIFIC CORP's stock rose 1.45% to $51.19, marking its fourth consecutive day of gains. source